- Home
- RMCF vs PMI Comparison
RMCF vs PMI Comparison
Compare RMCF & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMCF | PMI |
|---|---|---|
| Founded | 1981 | 1981 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | Specialty Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 14.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | RMCF | PMI |
|---|---|---|
| Price | $0.90 | $0.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 127.4K | ★ 10.0M |
| Earning Date | 06-16-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,432,352.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $0.09 |
| 52 Week High | $2.99 | $13.68 |
Technical Indicators
Market Signals| Indicator | RMCF | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 29.38 |
| Support Level | $0.84 | N/A |
| Resistance Level | $1.19 | $0.17 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 5.90 | 0.00 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.